Side Effects of BCG Bladder Treatment — What Is Normal, and When to Call

Most are urinary and short-lived. Burning while passing urine, going often and urgently, and a little blood in the urine are common for 24 to 48 hours after each dose. A low fever and body ache the same evening are expected too. A high fever that will not settle is not expected.

With that line drawn, here is what the ordinary weeks look like. BCG is a live, weakened bacterium instilled into the bladder through a thin catheter. The immune reaction it sets off inside the bladder wall is the treatment. Almost every expected side effect is that reaction being felt from the inside, which is why they are local, and why they arrive so soon after a dose.

• Burning or stinging while passing urine — the commonest complaint, usually strongest on the day of the dose and the day after.
• Going often, and urgently — the bladder holds less while it is inflamed. It settles as the inflammation does.
• A small amount of blood in the urine — pink or lightly blood-tinged urine in the first day or two is common and should still be reported.
• A flu-like evening — low fever, chills, tiredness and aching a few hours after the instillation, settling within a day or two.
• Mild cramping or pelvic discomfort — a dragging ache low in the abdomen for a day, without fever.
• Symptoms that build across the course — later doses often feel stronger than the first. That pattern is expected and is not, on its own, a reason to stop.

One thing worth saying plainly, because patients ask it constantly: how much you feel is not a measure of whether the treatment is doing its job. Some people have a strong local reaction and some have almost none. Whether the disease is being controlled is judged by cystoscopy, urine cytology and biopsy on the surveillance schedule your urologist sets — never by how sore the last dose made you.

Onset windows follow the patterns described in NCCN and ESMO patient-education material for intravesical BCG and used in Indian urology practice. Individual timing varies, and your own centre’s written instructions come first.

A BCG infection is when the live bacteria used in the treatment spread beyond the bladder and cause illness elsewhere in the body. It is uncommon. It is serious. It is treatable when it is recognised early. It can stay confined to the urinary tract, or it can become systemic — sometimes called disseminated BCG infection.

It is not the same thing as the flu-like evening after a dose, and it is not an ordinary urinary infection. It happens when bacteria that were meant to stay on the bladder lining get into the bloodstream, usually because the lining was not intact when the dose went in.

• What makes it more likely — a difficult or traumatic catheter insertion, a dose given too soon after resection, an active urine infection, visible blood at the time of instillation, or significant immunosuppression.
• What it feels like — fever with shaking chills, drenching night sweats, weight loss, a persistent cough, yellowing of the eyes or skin, or pain and swelling in a testicle.
• When it appears — sometimes within days of a dose, sometimes weeks or months later, which is exactly why it gets missed.
• How it is treated — a course of standard anti-tuberculosis medicines prescribed by the treating team, sometimes with a short course of steroids, and further BCG is normally stopped.
• What it is not — it is not tuberculosis caught from someone else, and it is not something you have passed on to your family.

Two practical consequences follow from all of this. The first is that instillations are postponed rather than pushed through when the urine is infected, when the catheter goes in with difficulty, or when the bladder is still raw after surgery — a delayed dose is a safety decision, not a setback. The second is that you should tell every doctor you see, for any reason, that you have had BCG into the bladder, for at least a year afterwards. A fever assessed without that information is assessed with a piece missing.

1. 1

   Six hours of toilet precautions

   For about six hours after the dose your urine still contains live BCG. Pass urine sitting down so nothing splashes, add roughly a cup of household bleach to the bowl, leave it fifteen to twenty minutes, then flush. Wash your hands afterwards. Wash any soiled clothing separately. Ordinary contact with your family is safe and there is no need to sleep apart or eat apart.

2. 2

   Drink more, not less

   The instinct when passing urine hurts is to drink less. It makes the burning worse, because concentrated urine irritates an already inflamed lining. Once the two-hour hold is over, drink freely for the rest of that day and the next. Cut back on tea, coffee and alcohol for 48 hours if you can, since all three add to urgency.

3. 3

   Measure the fever, do not estimate it

   Take your temperature the evening of the dose and the next morning, and write down the reading with the time. A low fever that peaks a few hours after the instillation and is gone by the next day is the expected pattern. A reading above 38.5°C that is still there after 48 hours, or a fever with shaking chills at any point, is not something to sit with at home — that is the same-day call described at the top of this page.

4. 4

   Do not start medicines on your own

   Take only the painkiller your own team has told you to take, at the dose they gave you. Do not start a leftover antibiotic from a previous illness because the burning feels like a urine infection. Some antibiotics act against the bacterium used in this treatment, and a dose taken privately can both interfere with the course and blur the one sign — a persistent fever — that your team is watching for.

5. 5

   Report everything before the next dose

   Keep one line per dose in a notebook or on your phone: what you felt, when it started, when it stopped, and the highest temperature. Hand that over before the next instillation, along with the urine test your centre asks for. This is what decides whether the dose is given on time, delayed a week, or reduced. A delayed dose is a normal part of a BCG course and is not a step backwards.

Use this table to decide how urgently to speak to someone, not to decide what you have. The overlap between the three is real, which is why a urine test before each dose is routine and why an unexplained fever after BCG is investigated rather than watched.

BCG is manufactured in India and used routinely across Indian urology practice, so the treatment itself is widely available. Supply is the weak point. Global and Indian shortages have interrupted courses before, and centres respond by adjusting the schedule or the dose rather than by promising continuity.

Several practical things follow from that, and they are worth knowing before they happen to you rather than after. When supply is tight, centres may split doses between patients, reduce the dose, shorten maintenance, or move to an alternative bladder instillation for part of the course. None of that is improvised — it is the recognised response to a shortage, and your urologist should tell you which of these is being done and why. If your course has been interrupted, what to do if BCG is unavailable sets out the options in more detail.

Two further points of honesty. Different manufacturers supply different preparations of BCG in different countries, and the side effects described on this page apply broadly across them; no ranking between them is claimed here. And several newer bladder-directed and systemic immune treatments that have been approved in the United States or Europe for bladder cancer are either not marketed in India or are available only in a small number of centres. If you have read about one of them, ask your urologist directly whether it can actually be obtained here before you build a plan around it.

BCG is also one of the oldest immunotherapies still in routine cancer care, which is why it can feel unfamiliar next to what people usually mean by the word. It works by non-specific immune stimulation inside one organ. That places it in the same broad family as the therapeutic cancer vaccines that exist today, and it is a useful reference point when reading the coverage of mRNA cancer vaccines — an area where headlines have moved considerably faster than approvals have. On cost, BCG is among the less expensive treatments in cancer care, but what you pay depends on the centre, the supply at the time and the number of doses in your schedule; any figure quoted to you is indicative only, as of August 2026.

Instillations are usually given by a urology team. If yours are being done elsewhere and you simply want a second reading of the side effects you are having, a CION medical oncologist can review them with you without taking over your treatment.

• BCG Shortage: What to Do If It Is Unavailable — what a supply interruption means for your schedule, and the recognised alternatives when a course cannot be completed as planned.
• Therapeutic Cancer Vaccines: What Exists Today — where a live bacterial treatment like BCG sits among the vaccine-style approaches, and what is genuinely available now.
• mRNA Cancer Vaccines: What the Headlines Actually Mean — a plain reading of the news coverage, including how far from routine care these still are.
• Immunotherapy at CION Cancer Clinics — the hub page: how immune treatments are given as day care, how side effects are monitored, and who to contact between cycles.

The fear of a fever is harder to carry than the burning

Urinary symptoms after every instillation wear people down. Not knowing where the line sits wears them down more. Our team will tell you exactly where that line is for you.